Computer-aided diagnosis of lung malignity using multidimensional analysis of tumour marker data
DOI:
https://doi.org/10.36547/nbc.1309Keywords:
lung malignity, multidimensional analysis, tumour markerAbstract
The aim of this work is assessing diagnostic performance of lung tumour markers. Three clinical laboratory tests were used for indicating lung malignancy in order to verify or predict the patient’s diagnosis. The data set of 182 patients was examined and two main groups of the patient samples were created – 86 with diagnosed malignancy (confirmed by histology) and 96 with diagnosed benign tumours or tuberculosis. The following tumour markers were analyzed: carcinoembryonic antigen and cytokeratin 19 fragment, which were sampled in the pleural exudates, and the same tumour markers in serum. In addition, the patient’s age and the gender of the corresponding individual were used as further variables in the original data matrix. Three laboratory tests were used for indicating lung malignancy in order to verify or predict the patient’s diagnosis not only by using the results of the chosen individual laboratory test but also applying multivariate statistical approach, which jointly utilizes all performed tests in the form of their optimal linear combination.Downloads
Published
2021-12-04
How to Cite
Mrázová, V., Mocák, J., Varmusová, E., & Kavková, D. (2021). Computer-aided diagnosis of lung malignity using multidimensional analysis of tumour marker data. Nova Biotechnologica Et Chimica, 8(1), 65–70. https://doi.org/10.36547/nbc.1309
Issue
Section
Research Articles
License
Copyright (c) 2021 Viera Mrázová, Ján Mocák, Elena Varmusová, Denisa Kavková
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers published in the Nova Biotechnologica et Chimica (NBC) are published under a CC-BY licence (CC-BY 4.0). Published materials can be shared (copy and redistribute the material in any medium or format) and adapted (remix, transform, and build upon the material for any purpose, even commercially) with specifying the author(s).